Concepedia

Mika Sunakawa

MS

4

Publications

179

Citations

4

H-Index

2016

Active since

Affiliations

Nippon Medical School(Current)

Mika Sunakawa is an author at Nippon Medical School specializing in tumor biology, immunotherapy, and tumor microenvironment.

Top concepts

MedicinePathologyImmunologyImmunotherapyTumor BiologyTumor MicroenvironmentApoptosisCell DeathAutoimmunityCell Biology

Publications per year

2016–2024

4

Publications

4

Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1

Mariko Ishibashi, Hideto Tamura, Mika Sunakawa et al. · Cancer Immunology Research · 2016 · 94 citations

Clinical impact of serum soluble SLAMF7 in multiple myeloma

Mariko Ishibashi, Saori Soeda, Makoto Sasaki et al. · Oncotarget · 2018 · 47 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cancer Immunosurveillance +14

SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma

Mariko Ishibashi, Risa Takahashi, Asako Tsubota et al. · Molecular Cancer Research · 2020 · 21 citations · Full text

Apoptosis, Immunology, Immune Regulation +25

Gelsolin alleviates rheumatoid arthritis by negatively regulating NLRP3 inflammasome activation

Jiyeon Lee, F Sasaki, Eri Koike et al. · Cell Death and Differentiation · 2024 · 17 citations · Full text

Rows per page

1–4 of 4